[go: up one dir, main page]

AU2646295A - Screening for cytokine modulators - Google Patents

Screening for cytokine modulators

Info

Publication number
AU2646295A
AU2646295A AU26462/95A AU2646295A AU2646295A AU 2646295 A AU2646295 A AU 2646295A AU 26462/95 A AU26462/95 A AU 26462/95A AU 2646295 A AU2646295 A AU 2646295A AU 2646295 A AU2646295 A AU 2646295A
Authority
AU
Australia
Prior art keywords
screening
cytokine modulators
cytokine
modulators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26462/95A
Inventor
Thomas Hermann
John W Pike
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ligand Pharmaceuticals Inc
Original Assignee
Ligand Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ligand Pharmaceuticals Inc filed Critical Ligand Pharmaceuticals Inc
Publication of AU2646295A publication Critical patent/AU2646295A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU26462/95A 1994-05-18 1995-05-15 Screening for cytokine modulators Abandoned AU2646295A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24547094A 1994-05-18 1994-05-18
US245470 1994-05-18
PCT/US1995/006524 WO1995031722A1 (en) 1994-05-18 1995-05-15 Screening for cytokine modulators

Publications (1)

Publication Number Publication Date
AU2646295A true AU2646295A (en) 1995-12-05

Family

ID=22926786

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26462/95A Abandoned AU2646295A (en) 1994-05-18 1995-05-15 Screening for cytokine modulators

Country Status (5)

Country Link
EP (1) EP0765475A1 (en)
JP (1) JPH10500485A (en)
AU (1) AU2646295A (en)
CA (1) CA2190275A1 (en)
WO (1) WO1995031722A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4436352A1 (en) * 1994-10-12 1996-04-18 Kay Brune Diagnostic assessment and follow-up procedures and medicines for the therapy of shock in humans
GB9424497D0 (en) * 1994-12-05 1995-01-25 Karobio Ab Reporter cell line
GB9608133D0 (en) * 1996-04-19 1996-06-26 Gemini International Holdings Diagnostic method and apparatus
US5728534A (en) 1996-07-19 1998-03-17 New England Medical Center Hospitals, Inc. Methods for identifying cardiovascular therapeutic agents
US6692928B1 (en) 1996-07-19 2004-02-17 New England Medical Center Hospitals, Inc. Methods for identifying cardiovascular agents
DE69635462T2 (en) * 1996-09-27 2006-08-17 The Board of Regents, The University of Texas System, Austin SCREENING METHODS FOR GLUCOCORTICOID RECEPTOR BINDING SUBSTANCES USING TRYPTERYGIUM WILFORDII PREPARATIONS
EP0987552A3 (en) * 1998-08-31 2000-06-07 Pfizer Products Inc. Diarylsulfonylurea binding proteins
CA2362071A1 (en) * 1999-02-18 2000-08-24 Chugai Seiyaku Kabushiki Kaisha Method for screening compound having affinity for vitamin d receptor
AU2001275530A1 (en) * 2000-06-08 2001-12-17 Board Of Regents, The University Of Texas System Inhibitors of c-reactive protein induced inflammation
PL368045A1 (en) * 2001-07-09 2005-03-21 Combinatorx, Incorporated Combinations for the treatment of inflammatory disorders
WO2003071281A2 (en) * 2002-02-25 2003-08-28 Akzo Nobel N.V. Estrogen receptor interaction with a transcription factor
AU2003304486A1 (en) * 2003-09-26 2005-04-14 Department Of Biogenic Amines, Polish Academy Of Sciences Cells and methods useful in characterising the immunotoxic activity of xenobiotic substances
US8519158B2 (en) 2004-03-12 2013-08-27 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
EP2511382A1 (en) * 2011-04-14 2012-10-17 Université de Strasbourg Process for identifying novel anti-inflammatory molecules with reduced direct transrepression of genes induced by glucocorticoids
JP2022529341A (en) 2019-04-19 2022-06-21 リガンド・ファーマシューティカルズ・インコーポレイテッド The crystalline form of the compound and the method for producing the crystalline form of the compound.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8946991A (en) * 1990-10-10 1992-05-20 La Jolla Cancer Research Foundation Method of inhibiting transcription utilizing nuclear receptors

Also Published As

Publication number Publication date
EP0765475A1 (en) 1997-04-02
JPH10500485A (en) 1998-01-13
WO1995031722A1 (en) 1995-11-23
CA2190275A1 (en) 1995-11-23

Similar Documents

Publication Publication Date Title
AU3018497A (en) Sifting screen
AUPM722194A0 (en) Bearer plate
EP0847362A4 (en) Gyroplane
AU3341395A (en) Vibration-compensating apparatus
AU1936895A (en) Shale shaker apparatus
EP0783147A3 (en) Modulator having individually placed edges
AUPN514395A0 (en) Screening apparatus
AU6932798A (en) Screening apparatus
AU3095595A (en) Dimension-measuring apparatus
AU2646295A (en) Screening for cytokine modulators
AU1226095A (en) Language-information providing apparatus
AU662683B2 (en) Screening arrangement
AU5413296A (en) Screening device
AU6155398A (en) Methods for screening for antibiotics
AUPM713094A0 (en) Screen construction
EP0791407A3 (en) Sifter
AU3652093A (en) Screening device
AU3860995A (en) Adjusting means
AU4472993A (en) Screening apparatus
AU7348796A (en) Screening arrangement
AU3878495A (en) Screening technique
AU696992B2 (en) Screening apparatus
AU6138596A (en) Binder
AU2725895A (en) Bearer plate
AU700529C (en) Screen construction